SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Losing a reward can affect your motivation and performance.

2.

Telemedicine services linked to reducing excess mortality

3.

Study finds 81% of cancer cures touted by TikTok videos are fake

4.

Surgery may not be necessary to treat invasive breast cancer

5.

Patients with head and neck cancer who cannot receive cisplatin now have new hope.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot